Literature DB >> 19812598

Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma.

Katie Ridd, Boris C Bastian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19812598      PMCID： PMC2825112          DOI： 10.1038/jid.2009.312

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  27 in total

1.  Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.

Authors:  G Lindner; A Menrad; E Gherardi; G Merlino; P Welker; B Handjiski; B Roloff; R Paus
Journal:  FASEB J       Date:  2000-02       Impact factor: 5.191

2.  Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.

Authors:  M F Di Renzo; M Olivero; T Martone; A Maffe; P Maggiora; A D Stefani; G Valente; S Giordano; G Cortesina; P M Comoglio
Journal:  Oncogene       Date:  2000-03-16       Impact factor: 9.867

3.  Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.

Authors:  Shih-hsin Kan; Navaratnam Elanko; David Johnson; Laura Cornejo-Roldan; Jackie Cook; Elsa W Reich; Susan Tomkins; Alain Verloes; Stephen R F Twigg; Sahan Rannan-Eliya; Donna M McDonald-McGinn; Elaine H Zackai; Steven A Wall; Maximilian Muenke; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2002-01-04       Impact factor: 11.025

4.  No evidence of somatic FGFR3 mutation in various types of carcinoma.

Authors:  M Karoui; H Hofmann-Radvanyi; U Zimmermann; A Couvelard; C Degott; L Faridoni-Laurens; J C Ahomadegbe; S Gazzeri; E Brambilla; T Clerici; P Charbonnier; C Tresallet; E Mitry; C Penna; P Rougier; C Boileau; J P Thiery; B Nordlinger; B Franc; F Radvanyi
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

5.  Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.

Authors:  K Kiguchi; D Bol; S Carbajal; L Beltrán; S Moats; K Chan; J Jorcano; J DiGiovanni
Journal:  Oncogene       Date:  2000-08-31       Impact factor: 9.867

6.  Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin.

Authors:  T Shimizu; H Izumi; A Oga; H Furumoto; T Murakami; R Ofuji; M Muto; K Sasaki
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

7.  Familial acanthosis nigricans due to K650T FGFR3 mutation.

Authors:  David R Berk; Elaine B Spector; Susan J Bayliss
Journal:  Arch Dermatol       Date:  2007-09

8.  Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.

Authors:  Shinobu Hosokawa; Shinichi Toyooka; Yoshiro Fujiwara; Masaki Tokumo; Junichi Soh; Nagio Takigawa; Katsuyuki Hotta; Tadashi Yoshino; Hiroshi Date; Mitsune Tanimoto; Katsuyuki Kiura
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

9.  Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.

Authors:  P M Pollock; M G Gartside; L C Dejeza; M A Powell; M A Mallon; H Davies; M Mohammadi; P A Futreal; M R Stratton; J M Trent; P J Goodfellow
Journal:  Oncogene       Date:  2007-05-21       Impact factor: 9.867

10.  An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis.

Authors:  L De Moerlooze; B Spencer-Dene; J M Revest; M Hajihosseini; I Rosewell; C Dickson
Journal:  Development       Date:  2000-02       Impact factor: 6.868
View more
  7 in total

Review 1.  [Current therapy of non-melanoma skin cancer].

Authors:  M Schlaak; W von Bartenwerffer; C Mauch
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

2.  Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial.

Authors:  William N William; Lei Feng; Renata Ferrarotto; Lawrence Ginsberg; Merrill Kies; Scott Lippman; Bonnie Glisson; Edward S Kim
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

3.  Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.

Authors:  Nicholas J Wang; Zachary Sanborn; Kelly L Arnett; Laura J Bayston; Wilson Liao; Charlotte M Proby; Irene M Leigh; Eric A Collisson; Patricia B Gordon; Lakshmi Jakkula; Sally Pennypacker; Yong Zou; Mimansa Sharma; Jeffrey P North; Swapna S Vemula; Theodora M Mauro; Isaac M Neuhaus; Philip E Leboit; Joe S Hur; Kyunghee Park; Nam Huh; Pui-Yan Kwok; Sarah T Arron; Pierre P Massion; Allen E Bale; David Haussler; James E Cleaver; Joe W Gray; Paul T Spellman; Andrew P South; Jon C Aster; Stephen C Blacklow; Raymond J Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 4.  Epidermal Growth Factor Receptor's Function in Cutaneous Squamous Cell Carcinoma and Its Role as a Therapeutic Target in the Age of Immunotherapies.

Authors:  Priscila Oliveira de Lima; Shannon Joseph; Benedict Panizza; Fiona Simpson
Journal:  Curr Treat Options Oncol       Date:  2020-02-03

5.  TRAF6 regulates EGF-induced cell transformation and cSCC malignant phenotype through CD147/EGFR.

Authors:  Xu Zhang; Lisha Wu; Ta Xiao; Ling Tang; Xuekun Jia; Yeye Guo; JiangLin Zhang; Jie Li; Yijing He; Juan Su; Shuang Zhao; Juan Tao; Jianda Zhou; Xiang Chen; Cong Peng
Journal:  Oncogenesis       Date:  2018-02-20       Impact factor: 7.485

Review 6.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.

Authors:  Natalia García-Sancha; Roberto Corchado-Cobos; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

Review 7.  The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts.

Authors:  Ignazio Stanganelli; Francesco Spagnolo; Giuseppe Argenziano; Paolo A Ascierto; Franco Bassetto; Paolo Bossi; Vittorio Donato; Daniela Massi; Cesare Massone; Roberto Patuzzo; Giovanni Pellacani; Pietro Quaglino; Paola Queirolo; Iris Zalaudek; Giuseppe Palmieri
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.